IL6 and COVID-19: Based on the results of our meta-analysis, especially promising markers are NLR, IL-6, serum ferritin, lymphocyte and CD4 counts, D-dimer and troponin I. The clinical value of these markers should be explored further to assess the risk of severe or critical disease and to monitor the clinical course of COVID-19.